In recent years, various inflammation markers and nutritional indicators, such as the neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR), prognostic nutritional index (PNI), and C-reactive protein (CRP)/albumin ratio (CAR), have been demonstrated to exhibit high utility in predicting surgical complications and prognosis in various cancers [9–11]. This evidence concerns the gene CRP and cancer.